NCT03436563: A reported trial by M.D. Anderson Cancer Center
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT03436563 |
|---|---|
| Title | A Phase Ib/II Trial of M7824 in Solid Tumors With Microsatellite Instability With Consensus Molecular Subtype 4 Metastatic Colorectal Cancer in Combination With Radiation, or in Colorectal Cancer Patients With Detectable Circulating Tumor DNA Following Definitive Therapy |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 7, 2018 |
| Completion date | Aug. 8, 2023 |
| Required reporting date | Aug. 7, 2024, midnight |
| Actual reporting date | Aug. 17, 2023 |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |